Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura H Franzke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|January 31, 2006
Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbedDaniel C Payne, Laura H Franzke, Paul A Stehr-Green, et al.
Journal of Public Health Management and Practice : JPHMP|January 25, 2024
Advancing Data Science Among the Federal Public Health Workforce: The Data Science Upskilling Program, Centers for Disease Control and PreventionMary Catherine P Bertulfo, Robert D Kirkcaldy, Laura H Franzke, et al.
Vaccine|January 11, 2012
Health-related quality of life in the Anthrax Vaccination Program for workers in the Laboratory Response NetworkBrock Stewart, Yujia Zhang, Charles E Rose, et al.
Pharmacoepidemiology and Drug Safety|February 18, 2005
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability programStacey W Martin, Bruce C Tierney, Aaron Aranas, et al.
Pharmacoepidemiology and Drug Safety|September 11, 2008
Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in womenYujia Zhang, Stacey W Martin, Charles E Rose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthraxBruce C Tierney, Stacey W Martin, Laura H Franzke, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|January 31, 2006
Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbedDaniel C Payne, Laura H Franzke, Paul A Stehr-Green, et al.
Journal of Public Health Management and Practice : JPHMP|January 25, 2024
Advancing Data Science Among the Federal Public Health Workforce: The Data Science Upskilling Program, Centers for Disease Control and PreventionMary Catherine P Bertulfo, Robert D Kirkcaldy, Laura H Franzke, et al.
Vaccine|January 11, 2012
Health-related quality of life in the Anthrax Vaccination Program for workers in the Laboratory Response NetworkBrock Stewart, Yujia Zhang, Charles E Rose, et al.
Pharmacoepidemiology and Drug Safety|February 18, 2005
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability programStacey W Martin, Bruce C Tierney, Aaron Aranas, et al.
Pharmacoepidemiology and Drug Safety|September 11, 2008
Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in womenYujia Zhang, Stacey W Martin, Charles E Rose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthraxBruce C Tierney, Stacey W Martin, Laura H Franzke, et al.
Pageof 1